The emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolism - Wikidata - wikimedia - TriplyDB

The emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolism

The emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolism

http://www.wikidata.org/entity/Q28072835

about

ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity N-(3-Benzoylphenyl)-1H-Indole-2-Carboxamide decreases triglyceride levels by downregulation of Apoc3 gene expression in acute hyperlipidemic rat model.Primary genetic disorders affecting high density lipoprotein (HDL)

P2860

Q33725659-1138CB89-ED37-4C4D-9CC8-24E49C62BAFA Q51113879-CC23587D-578A-47B7-A651-FEE9E86D82BC Q58751295-56913C72-0CEC-4952-98DB-7857CBCAC32F

P2860

The emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolism

http://www.wikidata.org/entity/Q28072835

description

2016 nî lūn-bûn

@nan

2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

The emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolism

@ast

The emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolism

@en

The emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolism

@nl

type

label

The emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolism

@ast

The emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolism

@en

The emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolism

@nl

prefLabel

The emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolism

@ast

The emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolism

@en

The emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolism

@nl

P1433

Q28072835-5DDC4582-43A1-4F01-B703-2E258B99C372

P1476

Q28072835-1CE709DC-EFC3-4FDD-9E45-95A5DD76CBC3

P2093

Q28072835-B1A9B951-7868-4540-8EF3-EFAD21CFC02C

Q28072835-DDCA1613-26F3-460A-B08F-230C9A31AB20

P275

Q28072835-AEDB7905-2D95-47D4-8794-C138E5FDB6F8

P2860

Q28072835-005721AD-C677-4E2B-91FB-D9820D8302F7

Q28072835-094245E9-7664-44F1-9BFD-08BC4C1B19EE

Q28072835-16407D29-C62E-4DBA-B0D6-E560C45D1082

Q28072835-1CA02330-476E-4DCB-AE2C-F74E2FC5FF0A

Q28072835-1F181D59-8E3C-49DD-9B1E-3E602C913428

Q28072835-2726E800-03EB-4622-AAEC-615B922F3E1B

Q28072835-39F53608-A82B-4D43-BEAE-F4DFE9EA0639

Q28072835-3A00E609-FAE8-40BA-A24E-FCE5A120595C

Q28072835-3C9711AB-8994-4530-966B-01A81535D0FC

Q28072835-4767C107-B95D-42CC-8DD1-02492CA4E194

P2888

Q28072835-6857DF82-E4F0-42D4-9D4F-5F652A540FBB

P304

Q28072835-75FAC2EE-13A3-4833-BE87-67691D39BECA

P31

Q28072835-1C03D866-5EFE-4C26-974D-45D85AFA2CA7

Q28072835-9DE3CD52-5AFF-4A23-89F8-5DD3954FFF17

P3181

Q28072835-23E0EA3E-564F-4E60-83C8-2D780A244D7E

P356

Q28072835-454B6790-A7B9-4555-A304-409166D4EB10

P407

Q28072835-76A00F58-6BB0-40C8-A6A3-0EED51809261

P433

Q28072835-97A55B3E-622E-4AB0-8C96-6BF5546BCA8B

P478

Q28072835-D8468064-CF96-4E76-B19B-50061740EAD3

P5008

Q28072835-E097B963-4C0C-47D0-9B85-D40210F660A3

P577

Q28072835-3A08071D-302D-45DC-9A04-B93F11315AD9

P6179

Q28072835-AADAA9D3-9521-48F7-A2D6-15A8F5C3A550

P698

Q28072835-F0C527E2-1AD4-4AA1-9E81-60C755937A4F

P921

Q28072835-359E8D66-6DFA-4F18-9140-B2627BCD7B18

Q28072835-41614972-E4E6-46BB-95AE-1510B90E43E3

Q28072835-7127BC05-C785-4C7F-83F0-7FBB6796AFE8

Q28072835-7C43CC66-15C5-4955-8F90-111A67DAB5F6

Q28072835-B98E1BBE-815C-4FAC-A33F-E96AB0021E40

Q28072835-C66BDC81-AA07-4805-A2D7-38B6C3EA5F8E

Q28072835-DBFCE14E-B847-4EB9-9015-DF24FA40E169

P932

Q28072835-9C9C0497-E7F8-4BF2-9010-3BD4F4393E03

P3181

P356

S12944-016-0352-Y

P1433

Lipids in Health and Disease

P1476

The emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolism

@en

P2093

Daoquan Peng

http://www.w3.org/2001/XMLSchema#string

Mengdie Luo

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Apolipoprotein C-III: understanding an emerging cardiovascular risk factor

Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions

Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemia

Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans

Common variants associated with plasma triglycerides and risk for coronary artery disease

Loss-of-function mutations in APOC3, triglycerides, and coronary disease

Statins suppress apolipoprotein CIII-induced vascular endothelial cell activation and monocyte adhesion

Mechanisms that regulate macrophage burden in atherosclerosis.

Effects of combination lipid therapy in type 2 diabetes mellitus.

The hemostatic system as a modulator of atherosclerosis.

P2888

s12944-016-0352-y

P304

184

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2846698

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/S12944-016-0352-Y

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2016-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1039394812

http://www.w3.org/2001/XMLSchema#string

P698

27770802

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

hypertriglyceridemia

clinical chemistry

P932

5075399

http://www.w3.org/2001/XMLSchema#string